Brief: Mayne Pharma Updates On Scheme Of Arrangement Update On FIRB Approval
Oct 31 (Reuters) - Mayne Pharma Group Ltd MYX.AX: MYX SCHEME OF ARRANGEMENT UPDATE ON FIRB APPROVAL TREASURER VIEWS PROPOSED ACQUISITION AS CONTRARY TO NATIONAL INTEREST COSETTE INTENDS TO CLOSE MAYNE PHARMA'S ADELAIDE SITE IF BOUGHT FIRB REQUESTS EXTENSION TO STATUTORY DEADLINE TO 1 DECEMBER 2025 COSETTE TO REQUEST FIRB FINAL DECISION BY 7 NOVEMBER 2025 Further company coverage: MYX.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mayne Pharma
See all newsBrief: Mayne Pharma Group Says It Settles Us Patent Litigation Re Imvexxy With Teva USA
Deals of the day-Mergers and acquisitions
Brief: Mayne Pharma Says Supreme Court Dismisses Cosette Appeal
Deals of the day-Mergers and acquisitions
Australian court dismisses Cosette appeal to drop Mayne Pharma takeover (updated)